When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Medical device company Novocure 's (NASDAQ: NVCR) shareholders have been cheering the company's recent success in its phase 3 clinical trial as the stock responded on the good news from an independent data monitoring company's positive findings. On a Fool Live episode recorded on April 14 , Fool contributors Brian Feroldi and Brian Withers discuss the company's recent news and whether the stock is now overvalued.